is a partner in the law firm NOVACOS, which specializes in pharmaceuticals and life sciences, and advises companies and associations primarily on questions of market access and reimbursement for drugs and medical devices in the statutory health insurance system. He is, among other things, a lecturer at the University of Marburg in pharmaceutical law, a member of the GRUR specialist committee “Medicine and Food Law”, and a member of the “Market and Reimbursement” committee of the Federal Association of Drug Manufacturers. V. (BAH) as well as a member of the “FB Market Access” and the “FB DRG” of the Federal Association of Medical Technology eV (BVMed).Other positions: